Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colombat

Showing results (171-180 of 257) with videos related to

Pageof 26
Sort By:
British Journal of Haematology|October 16, 1999
Secondary leukaemia and myelodysplasia after autografting for lymphoma: results from the EBMT. EBMT Lymphoma and Late Effects Working Parties. European Group for Blood and Marrow TransplantationD W Milligan, M C Ruiz De Elvira, H J Kolb, et al.
British Journal of Clinical Pharmacology|August 19, 2010
Influence of methotrexate exposure on outcome in patients treated with MBVP chemotherapy for primary central nervous system lymphomaHélène Blasco, Delphine Senecal, Amélie Le Gouge, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 3, 2020
Do anti-IL-6R blockers have a beneficial effect in the treatment of antibody-mediated rejection resistant to standard therapy after kidney transplantation?Maéva Massat, Nicolas Congy-Jolivet, Anne-Laure Hebral, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1990
The role of autologous bone marrow transplantation in 46 adult patients with non-Hodgkin's lymphomasP Colombat, N C Gorin, M P Lemonnier, et al.
Bone Marrow Transplantation|April 30, 2002
Persistent decrease in proliferative potential of marrow CD34(+)cells exposed to early-acting growth factors after autologous bone marrow transplantationJ Domenech, G Cartron, N Clement, et al.
European Journal of Cancer (Oxford, England : 1990)|November 30, 2000
Effect of cell determinant (CD)34+ cell dose on the cost and consequences of peripheral blood stem cell transplantation for non-Hodgkin's lymphoma patients in front-line therapyS Limat, M C Woronoff-Lemsi, N Milpied, et al.
Bulletin Du Cancer|January 1, 1990
[Primary non-Hodgkin's high grade malignant lymphoma of the digestive system. A prospective study of the combination of surgery-chemotherapy-radiotherapy]P Renou, P Colombat, F Fetissof, et al.
Advances in Hematology|October 29, 2014
Ethical and clinical aspects of intensive care unit admission in patients with hematological malignancies: guidelines of the ethics commission of the French society of hematologySandra Malak, Jean-Jacques Sotto, Joël Ceccaldi, et al.
American Journal of Respiratory and Critical Care Medicine|January 10, 2006
Pulmonary cystic disorder related to light chain deposition diseaseMagali Colombat, Marc Stern, Odile Groussard, et al.
Bone Marrow Transplantation|January 1, 1991
The TAM regimen prior to allogeneic and autologous bone marrow transplantation for high-risk acute lymphoblastic leukemias: a cooperative study of 62 patientsJ Y Cahn, P Bordigoni, G Souillet, et al.
Pageof 26

Showing results (171-180 of 257) with videos related to

Sort By:
Pageof 26
British Journal of Haematology|October 16, 1999
Secondary leukaemia and myelodysplasia after autografting for lymphoma: results from the EBMT. EBMT Lymphoma and Late Effects Working Parties. European Group for Blood and Marrow TransplantationD W Milligan, M C Ruiz De Elvira, H J Kolb, et al.
British Journal of Clinical Pharmacology|August 19, 2010
Influence of methotrexate exposure on outcome in patients treated with MBVP chemotherapy for primary central nervous system lymphomaHélène Blasco, Delphine Senecal, Amélie Le Gouge, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 3, 2020
Do anti-IL-6R blockers have a beneficial effect in the treatment of antibody-mediated rejection resistant to standard therapy after kidney transplantation?Maéva Massat, Nicolas Congy-Jolivet, Anne-Laure Hebral, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1990
The role of autologous bone marrow transplantation in 46 adult patients with non-Hodgkin's lymphomasP Colombat, N C Gorin, M P Lemonnier, et al.
Bone Marrow Transplantation|April 30, 2002
Persistent decrease in proliferative potential of marrow CD34(+)cells exposed to early-acting growth factors after autologous bone marrow transplantationJ Domenech, G Cartron, N Clement, et al.
European Journal of Cancer (Oxford, England : 1990)|November 30, 2000
Effect of cell determinant (CD)34+ cell dose on the cost and consequences of peripheral blood stem cell transplantation for non-Hodgkin's lymphoma patients in front-line therapyS Limat, M C Woronoff-Lemsi, N Milpied, et al.
Bulletin Du Cancer|January 1, 1990
[Primary non-Hodgkin's high grade malignant lymphoma of the digestive system. A prospective study of the combination of surgery-chemotherapy-radiotherapy]P Renou, P Colombat, F Fetissof, et al.
Advances in Hematology|October 29, 2014
Ethical and clinical aspects of intensive care unit admission in patients with hematological malignancies: guidelines of the ethics commission of the French society of hematologySandra Malak, Jean-Jacques Sotto, Joël Ceccaldi, et al.
American Journal of Respiratory and Critical Care Medicine|January 10, 2006
Pulmonary cystic disorder related to light chain deposition diseaseMagali Colombat, Marc Stern, Odile Groussard, et al.
Bone Marrow Transplantation|January 1, 1991
The TAM regimen prior to allogeneic and autologous bone marrow transplantation for high-risk acute lymphoblastic leukemias: a cooperative study of 62 patientsJ Y Cahn, P Bordigoni, G Souillet, et al.
Pageof 26